.ab893855.png&w=3840&q=75)
Rusan was the first company to launch Apomorphine subcutaneous injections for the effective management of Parkinson’s Disease in India under the brand APOSAN. APOSAN® is an advanced dopamine agonist therapy that helps manage OFF episodes—those difficult moments when traditional oral medications wear off and mobility decreases in the patient. Designed specifically for patients with Parkinson’s disease experiencing motor fluctuation. APOSAN® is available for all 5 stages of Parkinson’s in the following delivery forms: Injection Starter Kit, Self-Injector Pen for managing rescue and daily OFF episodes and the Pump for continuous infusion for advanced stages.
Improved bio-availability
Reduction in the OFF Time
Starts working in 4 to 10 minutes*.
Improved quality of life of patients and family members.
Reduction in hallucination and improved sleep at night time.
Ideal for dysphasic patients (Patients with a swallowing problem)
Programmable dose options tailored to patient needs.
Perfect for patients initiating Apomorphine therapy, the APOSAN Injection Starter Kit includes everything needed for a safe, supervised start. It supports clinicians and patients during the critical dose-adjustment phase to ensure optimal effectiveness and tolerability
Backed by clinical protocols for Parkinson’s care.
Ideal for first-time users of Apomorphine therapy.
Includes ampoules, injection tools and usage guide.
The APOSAN Pump offers a steady infusion of Apomorphine HCL for patients with advanced Parkinson’s disease who require continuous symptom control throughout the day. It reduces daily OFF time and smooths out fluctuations for more consistent motor performance.
Continuous delivery for stable symptom relief.
Supports long-term Parkinson’s management.
Programmable dose options tailored to patient needs.
